Patents by Inventor Joanne Adamkewicz

Joanne Adamkewicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
    Patent number: 11279762
    Abstract: The invention provides anti-idiotypic antibodies against anti-PD-L1 antibodies and methods of using the same.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: March 22, 2022
    Assignee: Genentech, Inc.
    Inventors: Jo-Anne Hongo, Angie Yee, Christine Tan, Joyce Lai, Joanne Adamkewicz, John Byon
  • IDIOTYPIC ANTIBODIES AGAINST ANTI-PD-L1 ANTIBODIES AND USES THEREOF
    Publication number: 20190338034
    Abstract: The invention provides anti-idiotypic antibodies against anti-PD-L1 antibodies and methods of using the same.
    Type: Application
    Filed: July 15, 2019
    Publication date: November 7, 2019
    Applicant: Genentech, Inc.
    Inventors: Jo-Anne Hongo, Angie Yee, Christine Tan, Joyce Lai, Joanne Adamkewicz, John Byon
  • KIFS as Modifiers of the RHO Pathway and Methods of Use
    Publication number: 20110111402
    Abstract: Human KIF23 genes are identified as modulators of the RHO pathway, and thus are therapeutic targets for disorders associated with defective RHO function. Methods for identifying modulators of RHO, comprising screening for agents that modulate the activity of KIF23 are provided.
    Type: Application
    Filed: September 24, 2010
    Publication date: May 12, 2011
    Applicant: EXELIXIS INC.
    Inventors: Joanne ADAMKEWICZ, Craig D. AMUNDSEN, Lynn Margaret BJERKE, George Ross FRANCIS, Timothy S. HEUER, Kim LICKTEIG, Monique NICOLL
  • Kifs as Modifiers of the Rho Pathway and Methods of Use
    Publication number: 20090004180
    Abstract: Human KIF23 genes are identified as modulators of the RHO pathway, and thus are therapeutic targets for disorders associated with defective RHO function. Methods for identifying modulators of RHO, comprising screening for agents that modulate the activity of KIF23 are provided.
    Type: Application
    Filed: November 9, 2006
    Publication date: January 1, 2009
    Applicant: Exelixis Inc.
    Inventors: Joanne Adamkewicz, Craig D. Amundsen, Lynn Margaret Bjerke, George Ross Francis, Timothy S. Heuer, Kim Lickteig, Monique Nicoll
  • Prkcs as modifiers of the beta catenin pathway and methods of use
    Publication number: 20070128606
    Abstract: Human PRKC genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of PRKC are provided.
    Type: Application
    Filed: August 13, 2004
    Publication date: June 7, 2007
    Applicant: EXELIXIS INC
    Inventors: Helen Francis-Lang, Christopher Winter, Richard Benn Ventura, Joanne Adamkewicz, Timothy Heuer
  • Mapk7 as modifier of branching morphogenesis and methods of use
    Publication number: 20070003927
    Abstract: Human MAPK7 genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of MAPK7 are provided.
    Type: Application
    Filed: October 22, 2003
    Publication date: January 4, 2007
    Inventors: Gregory Plowman, Felix Karim, Candace Swimmer, Hinrich Habeck, Thomas Koblizek, Stefan Schulte-Merker, Ulrike Langheinrich, Gordon Stott, Torsten Trowe, Andreas Vogel, Joerg Heinrich, Jochen Scheel, Torsten Will, Yisheng Jin, Joanne Adamkewicz